Literature DB >> 11583627

Structure and regulation of the CDK5-p25(nck5a) complex.

C Tarricone1, R Dhavan, J Peng, L B Areces, L H Tsai, A Musacchio.   

Abstract

CDK5 plays an indispensable role in the central nervous system, and its deregulation is involved in neurodegeneration. We report the crystal structure of a complex between CDK5 and p25, a fragment of the p35 activator. Despite its partial structural similarity with the cyclins, p25 displays an unprecedented mechanism for the regulation of a cyclin-dependent kinase. p25 tethers the unphosphorylated T loop of CDK5 in the active conformation. Residue Ser159, equivalent to Thr160 on CDK2, contributes to the specificity of the CDK5-p35 interaction. Its substitution with threonine prevents p35 binding, while the presence of alanine affects neither binding nor kinase activity. Finally, we provide evidence that the CDK5-p25 complex employs a distinct mechanism from the phospho-CDK2-cyclin A complex to establish substrate specificity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583627     DOI: 10.1016/s1097-2765(01)00343-4

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  68 in total

1.  Sumoylation of p35 modulates p35/cyclin-dependent kinase (Cdk) 5 complex activity.

Authors:  Anja Büchner; Petranka Krumova; Sundar Ganesan; Mathias Bähr; Katrin Eckermann; Jochen H Weishaupt
Journal:  Neuromolecular Med       Date:  2014-11-13       Impact factor: 3.843

2.  CDK5 interacts with Slo and affects its surface expression and kinetics through direct phosphorylation.

Authors:  Jun-Ping Bai; Alexei Surguchev; Powrnima Joshi; Liza Gross; Dhasakumar Navaratnam
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-16       Impact factor: 4.249

3.  Cyclin E constrains Cdk5 activity to regulate synaptic plasticity and memory formation.

Authors:  Junko Odajima; Zachary P Wills; Yasmine M Ndassa; Miho Terunuma; Karla Kretschmannova; Tarek Z Deeb; Yan Geng; Sylwia Gawrzak; Isabel M Quadros; Jennifer Newman; Manjusri Das; Marie E Jecrois; Qunyan Yu; Na Li; Frederic Bienvenu; Stephen J Moss; Michael E Greenberg; Jarrod A Marto; Piotr Sicinski
Journal:  Dev Cell       Date:  2011-09-22       Impact factor: 12.270

4.  Characterization of a new family of cyclin-dependent kinase activators.

Authors:  Ana Dinarina; Laurent H Perez; Amparo Davila; Markus Schwab; Tim Hunt; Angel R Nebreda
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

5.  Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism.

Authors:  Alexandr P Kornev; Nina M Haste; Susan S Taylor; Lynn F Ten Eyck
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-09       Impact factor: 11.205

6.  The structure of CDK4/cyclin D3 has implications for models of CDK activation.

Authors:  T Takaki; A Echalier; N R Brown; T Hunt; J A Endicott; M E M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 7.  Selectivity and potency of cyclin-dependent kinase inhibitors.

Authors:  Jayalakshmi Sridhar; Nagaraju Akula; Nagarajan Pattabiraman
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

8.  Amino acid sequence conservation of the algesic fragment of myelin basic protein is required for its interaction with CDK5 and function in pain.

Authors:  Andrei V Chernov; Albert G Remacle; Swathi K Hullugundi; Piotr Cieplak; Mila Angert; Jennifer Dolkas; Veronica I Shubayev; Alex Y Strongin
Journal:  FEBS J       Date:  2018-08-27       Impact factor: 5.542

9.  The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.

Authors:  Sonja Baumli; Graziano Lolli; Edward D Lowe; Sonia Troiani; Luisa Rusconi; Alex N Bullock; Judit E Debreczeni; Stefan Knapp; Louise N Johnson
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

10.  The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner.

Authors:  Rani Dhavan; Paul L Greer; Maria A Morabito; Lianna R Orlando; Li-Huei Tsai
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.